GPX1 and breast carcinoma: Considering the controversial effects of GPX1 polymorphism on breast cancer, a meta-analysis including six case-control studies was performed and revealed no significant correlation between GPX1 Pro198Leu polymorphism and breast cancer susceptibility in overall populations.